OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.
Times cited: 50
Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: A retrospective multicentre study on 33 patients.
British Journal of Haematology.
Times cited: 51
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.
Times cited: 487